Comparison Among Patients ≥75 Years Having Percutaneous Coronary Angioplasty Using Drug-Eluting Stents Versus Bare Metal Stents-Reference-Cited by-同舟云学术

Comparison Among Patients ≥75 Years Having Percutaneous Coronary Angioplasty Using Drug-Eluting Stents Versus Bare Metal Stents

Published:2015-05 Issue:9 Volume:115 Page:1179-1184
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Mangiacapra Fabio,Ricottini Elisabetta,Di Gioia Giuseppe,Peace Aaron,Patti Giuseppe,De Bruyne Bernard,Wijns William,Barbato Emanuele,Di Sciascio Germano

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions;Colombo;Acta Cardiol,2009

2. Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease;Kim;Circulation,2006

3. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

4. Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting;Puymirat;Am Heart J,2011

5. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial;Sabate;Circulation,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-year clinical outcome and predictors of ischemic and hemorrhagic events after percutaneous coronary intervention in elderly and very elderly patients;Coronary Artery Disease;2021-02-12

2. Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trial;International Journal of Cardiology;2017-09

3. Discretionary decisions and disparities in receiving drug-eluting stents under a universal healthcare system: A population-based study;PLOS ONE;2017-06-08

4. The SYNERGY II Everolimus elutiNg stent In patients Older than 75 years undergoing coronary Revascularisation associated with a short dual antiplatelet therapy (SENIOR) trial: rationale and design of a large-scale randomised multicentre study;EuroIntervention;2017-01

5. Efficacy and Safety of Percutaneous Coronary Intervention for Elderly Patients in the Second-Generation Drug-Eluting Stent Era: The SHINANO Registry;Angiology;2016-11-16